Tue, 20/03/2018 - 10:23
Sciad Communications, the science, tech and health communications consultancy, is pleased to announce its corporate sponsorship of OBN, the membership organisation supporting the UK’s innovative life sciences companies.
Bodo Spori
Mon, 12/03/2018 - 07:00
Cambridge, UK, 12th March 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is ple
Thu, 08/03/2018 - 11:51
London, Ongar, Cambridge, UK, 8th March 2018 / Sciad Newswire / A new collaboration in the efforts to find a new drug candidate to combat Parkinson’s has been ann
David Davies
Wed, 07/03/2018 - 07:30
Coventry, UK, 7th March 2018 / Sciad Newswire / Medherant Ltd, a leader in next-generation transdermal drug delivery, is
Tue, 27/02/2018 - 07:30
Newly patented hypergraph data model solidifies Riffyn’s position in the expanding market for linked-data analytics and AI in biotech and pharmaceutical R&D
Mon, 26/02/2018 - 07:30
Prokarium today announced the completion of a $10 million investment round. The round was led by Riyadh Valley Company, followed by Prokarium’s original investor Flerie Invest as well as Korea Investment Partners.
Bioforward poster
Mon, 19/02/2018 - 12:00
The ‘Roadmap for Growth’ Life Sciences Event
Mon, 05/02/2018 - 07:30
ReViral’s RV521 fusion inhibitor produces highly significant reduction in viral load and clinical symptoms
Thu, 01/02/2018 - 07:30
Cambridge, UK, 1st February 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is p
Wed, 31/01/2018 - 16:30
London, UK, 31st January 2018 / Sciad Newswire / 2018 will be a transformative year for UK healthcare as pioneering genomics companies identify people’s risk of d